Welcome to our Evotec Blog.

Hope you will find our articles and resources relevant for your projects and interests.

Our experts are available for any additional information and to assist with your project challenges!

Just contact us.

 

 

2018

Evotec and Immuneering to collaborate on Artificial Intelligence (“AI”) driven ligand identification for rare hereditary metabolic diseases
Nerina Coppini, 21 November 2018

Combination of cutting-edge IPSC and AI technologies creates opportunity to discover novel metabolic ligands to accelerate drug discovery in rare metabolic diseases

Evotec and Celgene expand IPSC collaboration to include additional cell lines
Nerina Coppini, 11 October 2018

$ 6 M payment to access additional cell lines

Evotec and CENTOGENE sign global strategic partnership on drug discovery projects in rare genetic diseases
Nerina Coppini, 27 August 2018

Joint drug discovery projects combine CENTOGENE’s patient access and biomarker expertise with Evotec's leading IPSC platform  

Evotec and Celgene expand IPSC collaboration to include additional cell lines
Nerina Coppini, 29 May 2018

$ 6 M payment to access additional cell lines

 

 

Contact us

Evotec

Business Development

T +44.(0)1235.86 15 61 T +1.732 329 2355 x3308